Current
Research in
Ophthalmology >>

A Randomized, Double Masked, Active Controlled Phase III Study of the Efficacy, Safety, and Tolerability of Repeated Doses of Intravitreal VEGF Trap in Subjects with Neovascular Age-Related Macular Degeneration- (CLEAR IT 3)

Principal Investigator

Richard Rosen, MD

Enrollment Status

Completed

Objective

To assess the efficacy of intravitreal (ITV) administered VEGF Trap compared to Lucentis (ranibizumab) in a non-inferiority paradigm in preventing moderate vision loss in subjects with all subtypes of neovascular AMD.

Contact Information

Anita Ou, CRC
(212)-979-4671

Katy Tai, CR Manager
(212) 979-4251

  

Home > Current Research > Clinical Trials in Ophthalmology > A RANDOMIZED, DOUBLE MASKED, ACTIVE CONTROLLED PHASE III STUDY OF THE EFFICACY, SAFETY, AND TOLERABILITY OF REPEATED DOSES OF INTRAVITREAL VEGF TRAP IN SUBJECTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION- (CLEAR IT 3)